TY  - JOUR
A1  - Tang, Mitchell
A1  - Nakamoto, Carter H.
A1  - Stern, Ariel Dora
A1  - Mehrotra, Ateev
T1  - Trends in remote patient monitoring use in traditional Medicare
JF  - JAMA Internal Medicine
N2  - This cross-sectional study uses traditional Medicare claims data to assess trends in general remote patient monitoring from January 2018 through September 2021.
Y1  - 2022
U6  - https://doi.org/10.1001/jamainternmed.2022.3043
SN  - 2168-6106
SN  - 2168-6114
VL  - 182
IS  - 9
SP  - 1005
EP  - 1006
PB  - American Veterinary Medical Association
CY  - Chicago
ER  - 
TY  - GEN
A1  - Tang, Mitchell
A1  - Nakamoto, Carter H.
A1  - Stern, Ariel Dora
A1  - Mehrotra, Ateev
T1  - Trends in remote patient monitoring use in traditional medicare
T2  - JAMA internal medicine
Y1  - 2022
U6  - https://doi.org/10.1001/jamainternmed.2022.3043
SN  - 2168-6106
SN  - 2168-6114
VL  - 182
IS  - 9
SP  - 1005
EP  - 1006
PB  - American Medical Association
CY  - Chicago, Ill.
ER  - 
TY  - JOUR
A1  - Essen, Anna
A1  - Stern, Ariel Dora
A1  - Haase, Christoffer Bjerre
A1  - Car, Josip
A1  - Greaves, Felix
A1  - Paparova, Dragana
A1  - Vandeput, Steven
A1  - Wehrens, Rik
A1  - Bates, David W.
T1  - Health app policy
BT  - international comparison of nine countries' approaches
JF  - npj digital medicine
N2  - An abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilitate the identification of safe and effective apps for health care practitioners and patients to generate the most health benefit as well as guide payer coverage decisions. Nearly all developed countries are attempting to define policy frameworks to improve decision-making, patient care, and health outcomes in this context. This study compares the national policy approaches currently in development/use for health apps in nine countries. We used secondary data, combined with a detailed review of policy and regulatory documents, and interviews with key individuals and experts in the field of digital health policy to collect data about implemented and planned policies and initiatives. We found that most approaches aim for centralized pipelines for health app approvals, although some countries are adding decentralized elements. While the countries studied are taking diverse paths, there is nevertheless broad, international convergence in terms of requirements in the areas of transparency, health content, interoperability, and privacy and security. The sheer number of apps on the market in most countries represents a challenge for clinicians and patients. Our analyses of the relevant policies identified challenges in areas such as reimbursement, safety, and privacy and suggest that more regulatory work is needed in the areas of operationalization, implementation and international transferability of approvals. Cross-national efforts are needed around regulation and for countries to realize the benefits of these technologies.
Y1  - 2022
U6  - https://doi.org/10.1038/s41746-022-00573-1
SN  - 2398-6352
VL  - 5
IS  - 1
PB  - Macmillan Publishers Limited
CY  - Basingstoke
ER  -